Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2003 2
2004 1
2005 1
2006 3
2008 1
2009 4
2010 3
2011 2
2012 9
2013 4
2014 2
2015 3
2016 2
2017 3
2018 3
2019 4
2020 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Hereditary paraganglioma.
Lemaire M, Persu A, Hainaut P, De Plaen JF. Lemaire M, et al. J Intern Med. 1999 Jul;246(1):113-6. doi: 10.1046/j.1365-2796.1999.00519.x. J Intern Med. 1999. PMID: 10447233 Free article.
The genetics of paragangliomas.
Burnichon N, Abermil N, Buffet A, Favier J, Gimenez-Roqueplo AP. Burnichon N, et al. Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Dec;129(6):315-8. doi: 10.1016/j.anorl.2012.04.007. Epub 2012 Oct 15. Eur Ann Otorhinolaryngol Head Neck Dis. 2012. PMID: 23078982 Free article. Review.
Identification of a germline mutation on the SDHB gene is a high-risk factor for malignancy and poor prognosis and requires close surveillance of subjects carrying this mutation. The diagnosis of hereditary paraganglioma also allows predictive genetic screening in f …
Identification of a germline mutation on the SDHB gene is a high-risk factor for malignancy and poor prognosis and requires close surveillan …
Paragangliomas: clinical overview.
Young WF Jr. Young WF Jr. Ann N Y Acad Sci. 2006 Aug;1073:21-9. doi: 10.1196/annals.1353.002. Ann N Y Acad Sci. 2006. PMID: 17102068 Review.
., with head and neck paragangliomas), incidental finding on imaging, or family screening for hereditary paraganglioma. Paragangliomas that hypersecrete catecholamines may cause signs and symptoms identical to those in patients with hyperfunctioning adrenal pheochro …
., with head and neck paragangliomas), incidental finding on imaging, or family screening for hereditary paraganglioma. Paraga …
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD. Rednam SP, et al. Clin Cancer Res. 2017 Jun 15;23(12):e68-e75. doi: 10.1158/1078-0432.CCR-17-0547. Clin Cancer Res. 2017. PMID: 28620007 Review.
Another neuroendocrine-related familial condition is the rapidly expanding hereditary paraganglioma and pheochromocytoma syndrome (HPP). The tumor spectrum for patients with HPP syndrome includes paragangliomas, pheochromocytomas, renal cancer, and gastrointestinal …
Another neuroendocrine-related familial condition is the rapidly expanding hereditary paraganglioma and pheochromocytoma syndr …
Genetic testing by cancer site: urinary tract.
Chan-Smutko G. Chan-Smutko G. Cancer J. 2012 Jul-Aug;18(4):343-9. doi: 10.1097/PPO.0b013e31826246ac. Cancer J. 2012. PMID: 22846736 Review.
The key features of 5 hereditary cancer susceptibility conditions involving an increased risk for RCC are discussed. von Hippel-Lindau disease, hereditary papillary RCC, and hereditary leiomyomatosis and RCC each predispose to a specific histological type of RCC, whereas Birt-Hog …
The key features of 5 hereditary cancer susceptibility conditions involving an increased risk for RCC are discussed. von Hippel-Lindau disea …
Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care.
Petr EJ, Else T. Petr EJ, et al. Semin Oncol. 2016 Oct;43(5):582-590. doi: 10.1053/j.seminoncol.2016.08.007. Epub 2016 Sep 21. Semin Oncol. 2016. PMID: 27899191 Review.
Over time, the number of endocrine tumor syndromes has significantly expanded, eg, with the recent inclusion of hereditary paraganglioma syndromes. Associations of non-endocrine tumors with hereditary endocrine tumor syndromes and endocrine tumors with non-classical …
Over time, the number of endocrine tumor syndromes has significantly expanded, eg, with the recent inclusion of hereditary paragan
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.
Ben Aim L, Maher ER, Cascon A, Barlier A, Giraud S, Ercolino T, Pigny P, Clifton-Bligh RJ, Mirebeau-Prunier D, Mohamed A, Favier J, Gimenez-Roqueplo AP, Schiavi F, Toledo RA, Dahia PL, Robledo M, Bayley JP, Burnichon N. Ben Aim L, et al. J Med Genet. 2022 Aug;59(8):785-792. doi: 10.1136/jmedgenet-2020-107652. Epub 2021 Aug 27. J Med Genet. 2022. PMID: 34452955 Free PMC article.
Hereditary paraganglioma targets diverse paraganglia.
Baysal BE. Baysal BE. J Med Genet. 2002 Sep;39(9):617-22. doi: 10.1136/jmg.39.9.617. J Med Genet. 2002. PMID: 12205103 Free PMC article. Review.
Consequently, patients with a paraganglioma tumour, including phaeochromocytoma, and a complex II germline mutation should be diagnosed with hereditary paraganglioma, regardless of family history, anatomical location, or multiplicity of tumours. ...
Consequently, patients with a paraganglioma tumour, including phaeochromocytoma, and a complex II germline mutation should be diagnosed with …
A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A, Venisse A, Nau V, Roncellin I, Boccio V, Le Pottier N, Boussion M, Travers C, Simian C, Burnichon N, Abermil N, Favier J, Jeunemaitre X, Gimenez-Roqueplo AP. Buffet A, et al. Horm Metab Res. 2012 May;44(5):359-66. doi: 10.1055/s-0032-1304594. Epub 2012 Apr 19. Horm Metab Res. 2012. PMID: 22517557 Review.
During the past decade, the discoveries of new paraganglioma/pheochromocytoma susceptibility genes and the subsequent progress of molecular screening techniques have enabled us to diagnose a hereditary paraganglioma/pheochromocytoma in about 22% of patients tested i …
During the past decade, the discoveries of new paraganglioma/pheochromocytoma susceptibility genes and the subsequent progress of molecular …
50 results